Jump to content
×
Are you looking for the BariatricPal Store? Go now!
  • entries
    43
  • comments
    93
  • views
    20,184

Fda Fibromyalgia Public Meeting On Patient-Focused Drug Development

FibroDiva

589 views

The Food and Drug Administration [FDA] is presenting an opportunity for our voices to be heard.

 

On December 10, 2013, FDA is conducting a public meeting on Fibromyalgia Patient-Focused Drug Development. FDA is interested in obtaining patient input on the impact of fibromyalgia on daily life (topic 1) and currently available therapies to treat the condition (topic 2). The questions for discussion on these topics are located at the bottom of this page.

 

For each of these topics, a panel of patients and patient representatives/advocates will present comments to begin the dialogue and will be followed by a facilitated discussion inviting comments from other patients and patient representatives.

If you are interested in providing comments as part of the initial panel discussion, indicate so during the registration process. Participants for the panel discussions will be confirmed prior to the meeting.

 

There will also be an opportunity for patients, patient representatives and others to provide comments on issues other than topics 1 and 2 during an Open Public Comment session. Sign up for Open Public Comment will take place the day of the meeting.

 

Don't worry if you cannot physically attend the meeting in Maryland, you can attend via webcast also.

 

click here for more information.



1 Comment


Recommended Comments

Well the FDA finally held the hearing. Oh, I forgot to post the original meeting of Dec 10, 2013 was rescheduled to March 26, 2014. The March meeting was fantastic. The FDA really wants to know how Fibromyalgia symptoms affect our quailty of life and what we think about medication.

I testified at the FDA Public Meeting on Patient Focused Fibromyalgia Drug Development and spoke about my experiences as a post-op patient. After the meeting I posted all the questions which the FDA needs community responses online [Click here for questions].

If you are a WLS patient with Fibromyalgia, please take a moment, click on the link above and copy and paste these questions to a word document, answer them and then go to http://www.regulatio...013-N-1041-0004 and paste your answers as comments onto the FDA docket. The comment now button is in the upper right corner of the FDA’s page.

The comment period closes on May 26, 2014. The FDA really needs to know that there is a subgroup of people with Fibromyalgia who need their medication in chewable, dissolvable or liquid forms.

Share this comment


Link to comment

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

PatchAid Vitamin Patches

×